Intellectus Partners, LLC
Source: SEC Form 13F · as of Mar 2026Intellectus Partners, LLC holds 25 biotech & pharma companies tracked by BioSniper, totaling $27.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
25
Total value held
$27.0M
| Company | Shares | Value |
|---|---|---|
| ZTSZoetis Inc. | 22,608 | $2.7M |
| ABBVAbbVie Inc. | 10,784 | $2.3M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,715 | $2.1M |
| ABCLAbCellera Biologics Inc. | 546,083 | $1.9M |
| LLYELI LILLY & Co | 1,726 | $1.6M |
| PFEPFIZER INC | 48,605 | $1.4M |
| ABTABBOTT LABORATORIES | 12,299 | $1.3M |
| CORTCORCEPT THERAPEUTICS INC | 31,000 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 8,947 | $1.2M |
| NUVBNuvation Bio Inc. | 290,417 | $1.2M |
| MRKMerck & Co., Inc. | 9,629 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 18,796 | $1.1M |
| NVONovo Nordisk A/S | 24,189 | $918K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,367 | $911K |
| MCKMcKesson Corporation | 1,021 | $884K |
| NTLAIntellia Therapeutics, Inc. | 54,475 | $698K |
| IDXXIDEXX LABORATORIES INC /DE | 1,219 | $685K |
| ELVElevance Health Inc. | 2,301 | $674K |
| JNJJOHNSON & JOHNSON | 2,690 | $657K |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 136,446 | $479K |
| NVSNovartis AG | 2,899 | $443K |
| RLAYRelay Therapeutics, Inc. | 42,225 | $420K |
| AMGNAMGEN INC | 1,059 | $373K |
| CMPSCOMPASS Pathways plc | 61,000 | $337K |
| CRSPCRISPR Therapeutics AG | 5,845 | $278K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.